Drug delivery system and method of use

Patent metadata

Field	Value
Publication number	US-11738146-B2
Application number	US-202015931364-A
Country	US
Kind code	B2
Filing date	May 13, 2020
Priority date	Jun 3, 2014
Publication date	Aug 29, 2023
Grant date	Aug 29, 2023

Abstract

A drug delivery system is disclosed that includes a drug delivery device having a reservoir and a delivery cannula having a proximal end in fluid communication with the reservoir and a distal end to be received within a patient. The drug delivery system may further include one or more sensors coupled to the drug delivery device, a wireless transmitter, and a controller coupled to the one or more sensors and the wireless transmitter. The controller may be configured to use the one or more sensors to determine a condition or an operational state of the drug delivery device, and control the wireless transmitter to wirelessly transmit one or more reports representative of the condition or the operational state of the drug delivery device. A method for use with a drug delivery device is also disclosed.

First claim

We claim:

1. A drug delivery device comprising:
a housing having an exterior surface;
an opening formed in the exterior surface of the housing;
a reservoir disposed at least partially within the housing;
a delivery member having a proximal end connected or configured to be connected in fluid communication with the reservoir and a distal end configured to extend through the opening in an operative state;
an adhesive disposed at the exterior surface of the housing for releasably attaching the drug delivery device to skin of a patient;
a removable cover coupled with the housing;
an electrical skin contact sensor disposed at the exterior surface of the housing; and
the drug delivery device being configured or programmed to:
(a) determine if the removable cover has been removed from the housing prior to or independent of use of the electrical skin contact sensor for sensing contact with the skin of the patient,
(b) alert the patient if or when the removable cover has been removed from the housing, and
(c) subsequent to (b), alert the patient if or when the drug delivery device has been triggered to deliver a drug to the patient.

2. The drug delivery device of claim 1 , comprising a controller coupled to the electrical skin contact sensor.

3. The drug delivery device of claim 2 , comprising a wireless transmitter coupled to the controller.

4. The drug delivery device of claim 3 , the controller being configured to determine if the drug delivery device is in contact with the skin of the patient based on output from the electrical skin contact sensor and control the wireless transmitter to wirelessly transmit a report representative of contact between the drug delivery device and the skin of the patient.

5. The drug delivery device of claim 2 , wherein the controller is programmed to repetitively determine at predefined time intervals if the drug delivery device is in contact with the patient.

6. The drug delivery device of claim 1 , wherein the removable cover comprises a sheet covering the adhesive and configured for removal by the patient or a user to expose the adhesive.

7. The drug delivery device of claim 6 , comprising a controller programmed to determine (a) if the adhesive has been exposed and (b) if the drug delivery device is in contact with skin of the patient and, if (b) does not occur within a predefined time period after (a), output a control signal to a controllable element.

8. The drug delivery device of claim 1 , the electrical skin contact sensor comprising a first electrically conductive member.

9. The drug delivery device of claim 8 , the electrical skin contact sensor comprising a second electrically conductive member.

10. The drug delivery device of claim 9 , wherein the first electrically conductive member, the second electrically conductive member, and the skin of the patient form a closed electrical circuit when the housing is in contact with the skin of the patient.

11. The drug delivery device of claim 9 , the opening being disposed between the first and second electrically conductive members.

12. The drug delivery device of claim 1 , wherein the adhesive and the electrical skin contact sensor are integrally formed.

13. The drug delivery device of claim 1 , wherein the drug delivery device is configured or programmed to alert the patient, via at least one light and/or at least one sound, if or when the removable cover has been removed from the housing.

14. The drug delivery device of claim 13 , wherein the drug delivery device is configured or programmed to alert the patient, via at least one light and/or at least one sound, if or when the drug delivery device has been triggered to deliver a drug to the patient.

15. The drug delivery device of claim 1 , wherein the drug delivery device is configured or programmed to alert the patient, via at least one light and/or at least one sound, if or when the drug delivery device has been triggered to deliver a drug to the patient.

16. The drug delivery device of claim 1 , wherein the drug delivery device is configured or programmed to alert the patient if or when the drug delivery device has been triggered to deliver the drug to the patient distinctly or separately from alerting the patient if or when the removable cover has been removed from the housing.

Assignees

• Amgen Inc

Inventors

• Mccullough Adam B
• Tamtoro Ferry
• Yang Huaying
• Lee Mark Ka Lai
• Yin Desheng
• Gibson Scott R
• Busby Donald
• Shultz Peter V
• Kogler Keith P
• Ward Jimmie L
• Folk Christopher R
• Badelt Steven William

Classifications

• G06Q10/40

  Business processes related to social networking or social networking services · CPC title

• G16H70/40

  relating to drugs, e.g. their side effects or intended usage · CPC title

• A61M2205/581

  by audible feedback · CPC title

• A61M2205/52

  with memories providing a history of measured variating parameters of apparatus or patient · CPC title

• A61M2205/502

  User interfaces, e.g. screens or keyboards · CPC title